PMC:7102556 / 12620-12877 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"243","span":{"begin":55,"end":63},"obj":"Species"},{"id":"244","span":{"begin":129,"end":137},"obj":"Species"}],"attributes":[{"id":"A243","pred":"tao:has_database_id","subj":"243","obj":"Tax:694009"},{"id":"A244","pred":"tao:has_database_id","subj":"244","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Jiang and colleagues have demonstrated that RBD in the SARS-CoV S protein is the major target of neutralizing antibodies in SARS patients and is able to induce highly potent neutralizing antibody responses and long-term protective immunity in animal models."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T73","span":{"begin":66,"end":73},"obj":"Body_part"},{"id":"T74","span":{"begin":187,"end":195},"obj":"Body_part"}],"attributes":[{"id":"A73","pred":"fma_id","subj":"T73","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A74","pred":"fma_id","subj":"T74","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"Jiang and colleagues have demonstrated that RBD in the SARS-CoV S protein is the major target of neutralizing antibodies in SARS patients and is able to induce highly potent neutralizing antibody responses and long-term protective immunity in animal models."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T44","span":{"begin":55,"end":63},"obj":"Disease"},{"id":"T45","span":{"begin":124,"end":128},"obj":"Disease"}],"attributes":[{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Jiang and colleagues have demonstrated that RBD in the SARS-CoV S protein is the major target of neutralizing antibodies in SARS patients and is able to induce highly potent neutralizing antibody responses and long-term protective immunity in animal models."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T138","span":{"begin":243,"end":249},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_33208"}],"text":"Jiang and colleagues have demonstrated that RBD in the SARS-CoV S protein is the major target of neutralizing antibodies in SARS patients and is able to induce highly potent neutralizing antibody responses and long-term protective immunity in animal models."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T73","span":{"begin":66,"end":73},"obj":"Chemical"}],"attributes":[{"id":"A73","pred":"chebi_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"Jiang and colleagues have demonstrated that RBD in the SARS-CoV S protein is the major target of neutralizing antibodies in SARS patients and is able to induce highly potent neutralizing antibody responses and long-term protective immunity in animal models."}

{"project":"LitCovid-sentences","denotations":[{"id":"T81","span":{"begin":0,"end":257},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Jiang and colleagues have demonstrated that RBD in the SARS-CoV S protein is the major target of neutralizing antibodies in SARS patients and is able to induce highly potent neutralizing antibody responses and long-term protective immunity in animal models."}